Use of the Randox Evidence Investigator immunoassay system for near-body drug screening during post-mortem examination in 261 forensic cases

P McLaughlin, PD Maskell, D Pounder… - Forensic science …, 2019 - Elsevier
Background This paper describes the performance of four Randox drug arrays, designed for
whole blood, for the near-body analysis of drugs in a range of post-mortem body specimens …

Real-time near-body drug screening during autopsy I: use of the Randox biochip drugs of abuse DOA I and DOA II immunoassays

P McLaughlin, D Pounder, P Maskell, D Osselton - Forensic Toxicology, 2013 - Springer
Screening for drugs of abuse is widely employed as part of forensic toxicology
investigations. The nature of specimens collected at autopsy varies depending on local …

Screening postmortem blood and tissues for nine cases of drugs of abuse using automated microplate immunoassay

KA Moore, C Werner, RM Zannelli, B Levine… - Forensic science …, 1999 - Elsevier
A commercially available enzyme-linked immunosorbant assay (ELISA) was evaluated as a
screening procedure for the detection of nine classes of abused drugs in postmortem blood …

Evaluation of the on-site immunoassay drug-screening device Triage-TOX in routine forensic autopsy

M Tominaga, T Michiue, H Maeda - Legal Medicine, 2015 - Elsevier
Instrumental identification of drugs with quantification is essential in forensic toxicology,
while on-site immunoassay urinalysis drug-screening devices conveniently provide …

Simultaneous quantitative analysis of 39 common toxicological drugs for increased efficiency in an ante-and postmortem laboratory

DC Mata, JF Davis - Forensic Science International, 2022 - Elsevier
Background A novel forensic method was developed to quantitate 39 drugs of toxicological
interest for ante-mortem and postmortem analysis. This method was created to combine and …

Setting cutoff concentrations for immunoassay screening of postmortem blood

IB Collison, VR Spiehler… - Journal of forensic …, 1998 - asmedigitalcollection.asme.org
The objective of this study was to establish the optimum immunoassay cutoff concentrations
for screening postmortem blood from coroner's cases for drugs of abuse with a coated tube …

Assessment of Triage DOA®, Status DS10, and DRIVEN-FLOW® M8-Z on-site drug screening kits for postmortem urine

T Tanaka, K Yoshida, K Kasai, S Yoshizumi, H Sato - Legal Medicine, 2022 - Elsevier
Based on the screening results of mass analyses using gas chromatography-mass
spectrometry (GC–MS) and liquid chromatograph-tandem mass spectrometry (LC-MS/MS) …

[PDF][PDF] Streamlined Unknown Screening for Postmortem Analysis

P Negri, OG Cabrices, D Fritch, M Stauffer, N Koenig… - AB Sciex, 2019 - lcms.cz
Gathering evidence to determine the cause of death is paramount in the service of the public
interest and the judicial process. To this end, accurate identification of drugs present in …

Validation of an automated microplate enzyme immunoassay for screening of postmortem blood for drugs of abuse

VR Spiehler, IB Collison, PR Sedgwick… - Journal of analytical …, 1998 - academic.oup.com
The objective of this study was to compare the sensitivity and specificity of an enzyme
immunoassay employing antibodies bound to a microtiter plate (MPEIA) with those of two …

Validation of a microtiter plate ELISA for screening of postmortem blood for opiates and benzodiazepines

P Kemp, G Sneed, T Kupiec… - Journal of analytical …, 2002 - academic.oup.com
The object of this study was to evaluate the suitability of the Neogen Corp. microtiter plate
enzyme-linked immunoassays (ELISA) for opiates and benzodiazepines for screening of …